Related by context. All words. (Click for frequent words.) 56 MHG Annual Report 52 without limitation EMRISE 52 risks anduncertainties 52 risksand uncertainties 52 Atheros Quarterly Report 51 otherrisks 50 EHSK 50 PPG Industries periodic 50 anduncertainties 50 ability tosuccessfully 49 i# implanters 49 Terremark filings 49 arenot limited 49 Equinix filings 49 ourbusiness 49 Luminex Reports 48 RTGV reports 48 EpiCept periodic reports 48 theseforward looking 48 market fluctuations investee 48 suchstatements 48 Omtool periodic reports 48 InfoSearch filings 48 Micromet Annual Report 48 SAN FRANCISCO Narin Leininger 48 Crisa acquisition 47 Immtech clinical trials 47 Form 8K #K 47 cause actualresults 47 thepossibility 47 Cytogen dependence 47 regarding Heska 47 filingswith 47 economicconditions 47 otherfactors 47 including withoutlimitation 47 uncertaintiesthat 47 ourability 47 CompAir acquisition 47 Favrille filings 47 TranSwitch indebtedness 47 Gilead Annual Report 46 NYSE PXP PXP 46 Martison Project 46 Freshest Beer Program 46 PGP Acquisition 46 Inovio Annual Report 46 caption Management Discussion 46 Micromet Quarterly Report 46 Bioenvision filings 46 Retalix Annual Report 46 Vocus filings 46 without limitation Terremark 46 BioSante licensees 46 couldcause actual results 46 looking statements.These 46 acquisitions divestitures joint ventures 46 Therein lurks 46 uncertainties impacting Sirit 45 ourproducts 45 PGxPredict tests 45 cause actual resultsto 45 newproducts 45 NII Holdings Annual Report 45 Company nanocrystalline materials 45 notlimited 45 candidate Ramoplanin 45 PDI periodic filings 45 XenoPort Quarterly Report 45 commercialize KRYSTEXXA 45 AtheroGenics Annual Report 45 Company Periodic Filings 45 HTA periodic 45 Selectica Annual Report 45 Auxilium Annual Report 45 futureresults 45 Carmanah Annual Report 45 EMCORE Annual Report 45 ARCADIS filings 45 GEROVA underwrites insurance 45 JLG acquisition 44 statementsare 44 maycause actual results 44 thispress release 44 Continuous Disclosure Defaults 44 theforward looking 44 Pervasip actual 44 Vion Annual Report 44 Gastar Annual Report 44 DURECT Form 44 Ultitek faces 44 Cautionary Statements section 44 acquisitions divestitures 44 ADSI reliance 44 technological innovations adversely affecting 44 vii IBC 44 Mediaseed R 44 VeraTag assays 44 statements arebased 44 couldcause 44 CompanyaEUR TM s 44 Lance Locurto 44 MacroChem actual 44 Dimension BST 44 AspenTech periodic reports 44 Sunesis clinical trials 44 Value Creation Plan 43 involve risksand uncertainties 43 anyforward looking 43 e# periodic 43 SINA Annual Report 43 bulk amorphous alloys 43 file INDs 43 Mr. Karbe 43 ManTech Annual Report 43 Theseforward looking 43 CAUTIONARY STATEMENT Estimates 43 contingent guaranties 43 risks associatedwith 43 doeth evil 43 concerning Alexza 43 verdict Bayrkdar 43 captions Item 1A 43 financialperformance 43 SavWatt filings 43 Photowatt France 43 Verint Systems Inc 43 borrower depositor 43 CORLUX CORT # 43 Cytogen periodic filings 43 commercialize Qutenza 43 causeactual results 43 Atheros Annual Report 43 Premature menopause 43 SA Asgi SA 43 Sting Tootsie 43 uncertainties 43 TranSwitch filings 43 looking statementsare 43 Palatin periodic filings 43 TTGL 43 Biophan anticipates 43 CGN SEDC 43 maydiffer materially 43 difficulties foreseeing 43 risksassociated 43 LandStar Inc. s 42 iii Cubist 42 Marbob acquisition 42 looking statements.Such 42 financialstatements 42 evaluating Questcor 42 affecting IsoTis 42 invoiced shipments 42 TSX VENTURE SSR 42 Orthodyne 42 InSite Vision filings 42 affect Zygo Corporation 42 Orvana Management Discussion 42 IFRS changeover 42 GigOptix periodic reports 42 TCG Opal specification 42 UMZ deposit 42 Proposed Transactions 42 CRHI 42 NHI Annual Report 42 suchforward looking 42 Align periodic 42 differ materially fromthose 42 OTCBB XSNX CEO 42 bi directional transformations 42 BioForce Nanosciences actual 42 uncertainties materialize Shire plc 42 distort comparability 42 fluctuate unpredictably 42 GreenCert ™ 42 companyaEUR TM s 42 ICx Technologies prospectus 42 Urocidin TM 42 involve risks anduncertainties 42 Acapodene R 42 command md5sum 42 Iusacell Celular 42 Alnylam dependence 42 PVR lessees 42 regardingthe 42 Company Prospectus dated 42 balance sheet deleveraging 42 DPX Survivac 42 Bioenvision dependence 42 AnnualReport 42 Risks uncertainties 42 offuture 42 GELV gasification technology 42 Varian Semiconductor dependence 42 Immtech scientists 42 Sonus Annual Report 42 CAUTIONARY STATEMENT Statements 42 headings Forward Looking 42 statementsregarding 42 BPE Segment 42 VioQuest Annual Report 42 epigenetic therapeutics 42 theCompany 42 USPR Annual Report 42 adversely affect Hologic 42 Securities andExchange Commission 42 APTIMA HPV assay 42 MicroTel 42 Realization Strategy 42 Constant Contact Quarterly Report 42 financialresults 42 unknown risks anduncertainties 42 Dr. Scangos 41 differmaterially 41 forward lookinginformation 41 eTag assays 41 concerning Xanthus 41 Rackspace Hosting Form 41 I. Item 1A 41 Heska filings 41 Zemiva TM 41 please visit http:/www.weingarten.com 41 nonoccurrence 41 react flexibly 41 BOPET film industry 41 differ materiallyfrom 41 MTI MTI Micro 41 withrespect 41 work stoppages slowdowns 41 aresubject 41 TeamStaff filings 41 forwardlooking statements 41 Allovectin 7 r 41 LDK Solar filings 41 lender consents 41 Second Supplemental Indenture 41 MultiCell bases 41 Kronos TiO2 41 HOMAG Group 41 caption Item 1A 41 obtaining regulatory approvals 41 Fabrinet focuses 41 Filing Statement dated 41 Si En 41 Dot VN filings 41 results ofoperations 41 Rexahn licensees 41 Cerro Negro concession 41 Purifine enzyme 41 AudioCodes filings 41 heading Risks Related 41 AN/USM-# 41 affecting BEO Bancorp 41 Form# Q 41 Spider Man aerial stunts 41 Absentee bids shall 41 DSL.net s 41 testosterone patch Intrinsa 41 Filtran Microcircuits Inc. 41 Master Commutation Release 41 BPEL processes 41 looking statementsaEUR describe 41 Refinancing Transactions 41 Synthetic Fuel segment 41 Invitel Holdings filings 41 historicalfacts 41 vii Cubist ability 41 OnForce marketplace 41 recompetes 41 Kevorkian Assisted 41 Terax Annual Report 41 deploy MDCE services 41 Voxware filings 41 hereof shall 41 website www.gladiatorstocks.com 41 Astro Med FY# 41 beyond Forent 41 Risk Factors Relating 41 theSecurities 41 limitedto 41 RR Donnelley periodic filings 41 oral NSAIDs 41 Forwardlooking statements 41 Nephros filings 41 headings Management Discussion 41 La.Code Crim.P. art 41 requisite stockholder 41 relocation visit www.ohiomeansbusiness.com 41 disciplines Merkle 41 deems immaterial 41 may diverge numerically 41 events orcircumstances 41 caption Risk Factors 41 forward lookingstatement 41 OneBeacon filings 41 Lockerby Depth Project 41 general economicconditions 41 areforward looking 41 counterparty defaults 40 Agria filings 40 Cautionary Disclosures 40 tofurther 40 uncertainties thatcould cause 40 Jinan Fertilizer 40 marketconditions 40 Repligen filings 40 theability 40 eTelcharge.com Inc. 40 reflect Ronn Motor 40 andoperating 40 mutually acceptable definitive 40 Somewhat mitigating 40 Forward lookingstatements 40 Quicksilver Resources filings 40 uncertainties materializes FICO 40 ImmunoGen Annual Report 40 Brooks Eckerd acquisition 40 Gemini Acquisitions 40 PVC Additives 40 Thesestatements 40 toreflect 40 concerning AudioCodes 40 intents beliefs 40 Compans 40 Zemiva TM Trofex TM 40 Partnered Brands segment 40 Medtronic Annual Report 40 Rexahn actual 40 product roadmaps 40 impair Lillian Vernon 40 Linktone filings 40 Exelbine 40 significantly tougher comparatives 40 results todiffer materially 40 Alexion Quarterly Report 40 theavailability 40 Thalomid R 40 unilateral moratoriums 40 IDIQ contracts 40 Neoware periodic 40 Unizan merger 40 Dowslake 40 indexation clauses 40 MacroChem Annual Report 40 sepsis infection Notaros 40 Surfaxin LS 40 Wikifamilies 40 thisrelease 40 Core competencies 40 forward lookingstatements 40 Condition Classification 40 Mago ® 40 VIOXX Lawsuits 40 projections anticipations 40 heading ITEM 1A 40 Tecstar Automotive Group 40 Suchforward looking 40 Ceragon Annual Report 40 Vitria Annual Report 40 Important Factors 40 JAVACO 40 actualresults 40 headings Risks Related 40 adopting SFAS #R 40 Yima project 40 SANCTURA R 40 regarding allosteric modulators 40 Modavox filings 40 Heska reliance 40 Palatin intends 40 subclassified based 40 Andrew Kokoraleis 40 GEHC 40 Gilead Quarterly Report 40 andmarket 40 concerning Epigenomics AG 40 Cautionary Statement Regarding 40 Viability Plan 40 SIMOX SOI 40 timing rescheduling 40 DURECT Quarterly Report 40 Vital Images SEC 40 ARLP Partnership 40 supplemental indenture effecting 40 cancellations rescheduling 40 minimally dilutive 40 Amrozi Imam Samudra 40 molecular diagnostic reagents 39 Form# K 39 rPA vaccine candidate 39 Repurchase Offer Notice 39 GenVec filings 39 Federal Mogul Alapont 39 Legerity acquisition 39 concerning InfoSonics 39 SciClone filings 39 SearchHelp communications 39 unscheduled outages 39 ii Immtech ability 39 Mr. Hawatmeh 39 GUIDANCE AND 39 product introductions 39 DTR#.#.# h 39 CuraGen Quarterly Report 39 proprietary Capillary Aerosolization Technology 39 Merger Arb ETF 39 GLJ Report 39 Radware filings 39 VanceInfo filings 39 RCUs 39 Pashminadepot.com 39 ICT GROUP 39 BLA filing 39 SumTotal Systems filings 39 VimpelCom disclaims 39 consents authorizations 39 Item 7A Quantitative 39 novel therapeutic modality 39 party VLSI fabrication 39 Odessa Brody Gdansk 39 Shire plc Attention Deficit 39 XFMedia filings 39 Qinnan PSC 39 affect Pennichuck Corporation 39 Rosetta dependence 39 andfinancial 39 Hycroft Mine 39 forwarda ^ looking 39 futureperformance 39 Aimco Annual Report 39 Prospectuses contain 39 HandHeld Entertainment filings 39 AIF identifies 39 vii 39 heading RISK FACTORS 39 CLM feasibility study 39 Whoever defames 39 cedents 39 GHN Agrispan 39 Signalife filings 39 inflationary pressures adversely affecting 39 EGRIFTA TM 39 Beta coefficient 39 Varvarinskoye Project 39 viii inability 39 Risk Factors Legal Proceedings 39 website StockMarketLife.com 39 See www.claymore.com CEF 39 Risk Informer 39 Innotrac Website www.innotrac.com 39 www.weingarten.com 39 Metretek Florida 39 QSound periodic reports 39 mso font format 39 Lasertel subsidiary 39 BioGold Fuels 39 Aastrom Annual Report 39 Flamel Annual Report 39 PV module efficiencies 39 OVP simulator 39 Intellon ICs 39 Securitiesand Exchange Commission 39 Fab2 capacity 39 InterRent publicly 39 website aStockMarketLife.com 39 attorney WH Newbold 39 obj obj = 39 torsemide ER 39 adversely affect Univest Corporation 39 BPLP 39 EGTT 39 CHDT SEC Filings 39 Bionutrics 39 viabilities 39 Sonus Quarterly Report 39 uncollectable receivables 39 execute 39 Nuvelo filings 39 Chase Kishner 39 Offering Memorandum dated 39 Attunity Annual Report 39 Arbortext IsoDraw 39 CEO Magnus Ryde 39 Exelixis Quarterly Report 39 supplemental indenture containing 39 delinquencies defaults 39 force majeure clauses 39 Improper braking 39 Shaheer Ali 39 Company periodic filings 39 Bioaccelerate compounds under 39 OREO valuation 39 cadence regulatory approvals 39 Factors Affecting Future 39 CLX Investments 39 ReCyte 39 subjectto 39 ADSI ability 39 Wilhelmina Companies 39 PolyMedix filings 39 Management Proxy Circular 39 Assumptions underlying 39 PD2i ® algorithm 39 todiffer materially 39 killer Romell Broom 39 Navios Partners filings 39 missed Absentee Bids 39 affect Petroflow 39 affecting Attunity 39 ERP SyteLine 39 spokeswoman Barbara Kracht 39 website www.octoplus.nl 39 Kyowa Kirin 39 whichcould 38 Syntroleum Process 38 SILENOR ™ 38 website StockPreacher.com 38 facilities SEFs 38 WNS ADS 38 PROLOR filings 38 applicable Offering Memorandum 38 DataWorld 38 Azedra ™ 38 IEVM 38 exhibits thereto 38 Cautionary Statements 38 UNOCI mandate 38 NES Clothing 38 dispositions joint ventures 38 Liftking 38 HANA MAX 38 Quantitative Disclosures About 38 Firstgold Corp. s 38 Subordinate MBS 38 Lebowa transaction 38 ASUR filings 38 expressed orimplied 38 risks associated therewith 38 QuIC Analyzer 38 Narin Leininger knows 38 TransVax tm 38 Monster Worldwide Form 38 Compound Semiconductors 38 iii 38 Westell Annual Report 38 Copano commodity 38 xvi 38 commercialize ZYFLO CR 38 Inc. NASDAQ TRMP 38 OSI Pharmaceuticals filings 38 Mr. Feldenkreis 38 itsbusiness 38 vii Dynamic 38 tiny pteropod 38 GulfMark filings 38 realizability 38 VELCADE therapy 38 KRYSTEXXA TM 38 impacting WesBanco 38 iv 38 SFAS# R 38 Annual Report 38 GM BRNC 38 commercialize BiDil 38 NASDAQ CVV 38 Override Agreement 38 nothistorical facts 38 M. Achary 38 ExchangeCommission 38 Chief Executive Gregory Spierkel 38 thedate 38 divestures 38 Merger Transactions 38 includingstatements regarding 38 recontracting 38 e mail lifestyle@readingeagle.com 38 Radiant Logistics logistics.com 38 Introgen filings 38 McDermott Wuchuan 38 periodic redeterminations 38 incorporating FalconStor 38 recategorization 38 APPY believes 38 Pharmos filings 38 Mitigating factors 38 Item IA 38 GPMT 38 commercialize technological innovations 38 contained inthis 38 Timminco Annual 38 visit http:/accelrys.com/ 38 condensed consolidated balance sheets 38 PETER PASSI covers 38 thoseexpressed 38 GoFish periodic filings 38 retroactive restatement 38 adipokines 38 CriticalControl enables 38 Nortel remedial 38 SAFE HARBOR Certain 38 lorcaserin NDA 38 products visit www.adm.com 38 Yucheng filings 38 economically recoverable coal 38 viii 38 develop electroporation 38 Quantum periodic filings 38 Fampridine SR Acorda Therapeutics 38 OctoPlus NV 38 EMPOWER pivotal trial 38 unexecuted orders 38 UBCI Annual Report 38 Ravelston Entities 38 Tucows filings 38 accompanying condensed consolidated 38 Pertra 38 omecamtiv mecarbil 38 Form #Q 38 VIVUS Form 38 EPIXTAR 'S 38 highly leveragable 38 GrowthWorks refers 38 Kensington Leasing 38 Domilens 38 Azedra TM Onalta TM 38 Largo website www.largoresources.com 38 Petrofund merger 38 carryforwards 38 Cheniere Partners 38 IVAX Annual Report 38 PLK1 SNALP 38 Non Correlation 38 Fischer Zoth 38 Syntax Brillian Annual Report 38 involverisks 38 Cellceutix actual 38 Projects Initiation 38 supplemental indenture implementing 38 ProUroCare filings 38 Mladic Ljajic 38 Qualstar filings 38 Spike Jonze cinematic 38 storm Heusdens 38 Lyron Bentovim 38 inventory obsolescence 38 PeopleMed TM Inc. 38 Zi OEM 38 barrenwort extraction efficiency 38 unanticipated geological 38 Shell Lubricants collectively 38 currentexpectations 38 SBA loan originations 38 xiv litigation 38 Biological License Application 38 asset monetizations 38 OrCrude TM process 38 Rs.2 #cr 38 Web site http:/www.EmergingStockReport.com 38 initiate multicenter 38 Statement Statements 38 Abraxas filings 38 reflect Ronn Motors 38 starvation overwork torture 38 Packeteer Form 38 Evader Inc. 38 products andservices 38 Current Reports 38 Metabasis Quarterly Report 37 theacquisition 37 Supplemental Indentures 37 chanting slogans vowing 37 unfavorable variances 37 Balqon Corporation filings 37 DARA intellectual property 37 similarexpressions 37 toimplement 37 SAIC Annual Report 37 reflecting Maximizer Software 37 Fluctuating commodity 37 GigaMedia cautions readers 37 Specifications pricing 37 Verenium dependence 37 concerning Wowjoint 37 footnotes thereto 37 Dynavax Annual Report 37 partner Mallinckrodt Imaging 37 San Cristóbal mine 37 PRECISE trial 37 BLVT BulovaTech 37 molecular immunohematology products 37 auditors PricewaterhouseCoopers LLP 37 Administaff filings 37 Harsco Rail 37 Trimeris Form 37 Shire Attention Deficit 37 Entereg TM 37 Statement Regarding Forward Looking 37 Videolocity International Inc. 37 Orosi Mill project 37 prospectus supplement dated 37 uVuMobile Annual Report 37 Bobby Yazdani Chairman 37 TomoTherapy judgments 37 OneBeacon Annual Report 37 SILENOR 37 affecting Zone4Play 37 Eline Entertainment Group 37 Verena filings 37 performance compliances certifications 37 Sepracor licensees 37 eLinear Annual Report 37 representations warranties covenants 37 FSP #-# 37 PalWeb 37 acquisitions mergers dispositions 37 cause actual 37 Enpath ability 37 HealthGate ability 37 website www.corcept.com 37 PharMerica LTC Transaction 37 Bairnco stockholders 37 ideal biocide 37 HP Quarterly Report 37 affecting Pluristem 37 herein 37 AMETEK filings 37 website www.aeroflex.com 37 Tollerud committee 37 visit http:/www.nationwide.com 37 Infor ERP XA 37 ceoforum.com.au How 37 Form 8K filed 37 AND ON FORM 37 Behavioral Analytics 37 These statementsare 37 TRISENOX ® 37 SmartHeat filings 37 Applehead I. 37 Company TSX CQE 37 CIP TRAMADOL ER 37 POZEN website www.pozen.com 37 caption Factors 37 looking statements.The 37 abilityto 37 Healthvision acquisition 37 mutually satisfactory definitive 37 visit www.jbhunt.com 37 andmanagement 37 condensate splitter 37 CommVault beliefs 37 OraTest R 37 BigBand periodic 37 consummating acquisitions 37 productization 37 Interpretative Communication 37 Form #Q filed 37 affecting Amarin 37 caption Forward Looking 37 thetransaction 37 Z5 Technologies 37 PURPOSE OF SAFE HARBOR 37 succeed Zamost 37 4S eConnect 37 developments affecting SIAF 37 ePort devices 37 AndeanGold website 37 Vyvx advertising 37 APNB 37 operated bakery cafes 37 Shahid Jamil Riaz Jamil 37 execution 37 SpectraScience actual 37 looking statements includingbut 37 Babines classes 37 reflect VIQ Solutions 37 definitive documentation 37 earnings pershare 37 EPIX Pharmaceuticals 37 Such forwardlooking statements 37 infrequently occurring 37 affecting AltiGen 37 nationalist Padraic Pearse 37 adjusted EBITDAS 37 Taleo Annual Report 37 Chordiant logo 37 continual refinement 37 Voraxaze 37 Prospectus Supplement filed 37 projections interpretations prognoses 37 intermarket relationships 37 Guinea Alumina Refinery 37 Genaera filings 37 ITworld privacy 37 Ascendiant 37 CPI Aero Form 37 Juhl Wind subsequent 37 multi frac 37 hateful taunts 37 androgen depletion therapy 37 LNP formulations 37 inherent uncertainty 37 Tulsequah Project 37 Offset Obligation 37 RHFS 37 financing Clairvest contributes 37 · Coordinate 37 condensed consolidated interim 37 Inovio Biomedical AMEX INO 37 includes DRAM SRAM 37 continuously reinvents 37 TGS reliance 37 HealthTronics periodic filings 37 contingencies 37 theglobe.com inc 37 EMPOWER TM 37 pricing pressures 37 reflect SpatiaLight 37 ICH guidelines 37 Dr. Ash Rofail 37 NxStage anticipates 37 factors thatcould 37 Oncore TM 37 ITG TCA 37 Hiru Corporation 37 TSX VENTURE VV 37 Col. Ryadh Gatie Olyway 37 amortized ratably 37 strategies 37 xix 37 xv 37 postretirement benefit 37 PD2i Cardiac Analyzer 37 proprietary StoresOnline software 37 businesses trademarks tradenames 37 ENABLE Phase 2 37 accompanying Explanatory Memorandum 37 Asentar TM 37 please visit www.medicinova.com 37 definitization 37 unabsorbed overhead 37 please visit www.memc.com 37 website www.PennyStockAlley.com 37 LPM TM 37 offerings visit www.balqon.com 37 Acorda Therapeutics filings 37 specifically Axonyx 37 BiDil XR 37 GSCT 37 Plastic2Oil sites 37 ADVENTRX 37 regarding AngelCiti 37 QLT Annual Report 37 factors 37 visit http:/www.clicksoftware.com 37 biostatistical analysis 37 requirements xxii 37 Proligo 37 Passendro 37 DeeThree 37 Nortel strategic alliances 37 impactof 37 xviii 37 iGlucose system 37 www.solerainc.com 37 especially Copaxone ® 37 Unigene Biotechnologies 37 Gary J. Cotshott 37 xvii 37 Hifn filings 37 reflect DTRO 37 molecules Air Liquide 37 Oxandrin 37 visit http:/www.chinawindsystems.com 37 Diversified Status 37 Akamai Adobe 37 early modernist sculptors 37 site www.buyins.net 37 RXi Pharmaceutical Corporation 37 adversely affect Curis 37 PD2i Analyzer ™ 37 visit http:/www.cytrx.com 37 ceded reinsurance 36 FalconStor OEM 36 Xphase principals 36 ofnew 36 KRIs 36 CDO financings 36 periodic reports 36 PLIVA acquisition 36 Vion Form 36 constituteforward looking 36 brine inflows 36 Biomerica contains 36 SSA GT 36 EdgeStone Funds 36 bardoxolone 36 http:/www.vandapharma.com 36 affect theglobe.com 36 SunSi 36 CIGSolar ™ 36 Form# F 36 update anyforward looking 36 areas Fertility Transplantation 36 Form 8K 36 MODCOMP 36 DealerTrack Inventory Optimization 36 xiii 36 CEDC Form 36 companiesâ € ™ 36 Mining Mandate 36 Bomber Timothy McVeigh 36 Xechem Nigeria 36 please visit www.ldksolar.com 36 ELEVESS 36 JUVISTA 36 generic Copaxone 36 PLAVIX R patent 36 Anadys SEC 36 RIGScan CR 36 Chief Executive Jouko Karvinen 36 SupportSoft assumes 36 Northshore varies 36 Enova Systems periodic filings 36 Application Delivery Networks 36 Michael Silton commented 36 Dan O. Dinges 36 Aeolus Annual Report 36 Cruel mob 36 #QSB 36 http:/www.solerainc.com 36 Dr. Gulfo 36 collaborations Pharmacopeia 36 Taleo Quarterly Report 36 ENRICH trial 36 AIMM trial 36 manufacture PolyHeme 36 CorMedix filings 36 MTFP 36 Minefinders Annual 36 Yiyang Yukang 36 visit http:/www.exar.com 36 hematopoietic malignancies 36 PHAZAR CORP 36 Landdrill 36 Franke Mine 36 NetChip 36 Dyax phage display 36 website www.tecsys.com 36 patented Bioral R nanocochleate 36 Form #K 36 inventories revalued 36 market PolyHeme commercially 36 http:/investors.formfactor.com/edgar.cfm 36 covenant defaults 36 Penwest Quarterly Report 36 Biophan periodic filings 36 Mr. Xianshou Li 36 unfavorable geologic 36 performance indicators KPI 36 differing materially 36 uncertainties materialize Shire 36 regarding Anviron 36 contemplated therein 36 xxvii 36 Certain Factors Affecting 36 LightPath commented 36 macroprudential supervision 36 Cardenas Tabasco 36 gaffe prone provocateur 36 Kosan dependence 36 gunman Giuseppe Zangara 36 Alamos Annual 36 LA GO GO 36 No. #R 36 love veronica Mars 36 Mohammad Reza Haddadi 36 hpSCs avoid ethical 36 S#D Publishing Suite 36 Bluepoint delivers 36 Convicted murderer rapist 36 Accelr8 licenses 36 Black Canyon mica 36 accretion dilution 36 faith Stollmack 36 Reorganized Debtors 36 liposome formulations 36 workplans 36 FSRU conversions 36 andour 36 Axia Group 36 Peer Schatz QIAGEN 36 HTDS Corporation 36 please visit www.comstockhomebuilding.com 36 @ y qW 36 LLC XGen 36 ADSI cautions 36 Borgakim 36 fighter jets del Rosario